Literature DB >> 12470655

Identification of genes induced by BRCA1 in breast cancer cells.

Arzu Atalay1, Tim Crook, Mehmet Ozturk, Isik G Yulug.   

Abstract

Inherited mutations of the BRCA1 gene predispose to breast, ovarian, and other cancers. The role of the BRCA1 gene in the maintenance of chromosomal integrity is linked to a number of biological properties of its protein product, including transcriptional regulation. In the present study, we have used suppression subtractive hybridisation (SSH) to identify genes induced by BRCA1 by comparing control MCF7 breast carcinoma cells (driver) with MCF7 cells ectopically expressing BRCA1 (tester) and generated a forward subtracted cDNA library. We screened 500 putative positive clones from this library. Two hundred and ten of these clones were positive by differential screening with forward and reverse subtracted probes and the 65 cDNA clones which showed more than fivefold increase were selected for sequencing analysis. We clustered 46 different genes that share high homology with sequences in the GenBank/EMBL databases. Among these, 30 were genes whose function had been previously identified while the remaining 16 clones were genes with unknown functions. Of particular interest, BRCA1 gene induces the expression of genes encoding DNA repair proteins RAD21 and MSH2, ERBB2/HER2 interacting protein ERBIN, meningioma-associated protein MAC30, and a candidate ovarian tumour-suppressor OVCA1. Northern and Western blot analyses confirmed that the expression of these five genes are up-regulated following BRCA1 overexpression in MCF7 and UBR60-bcl2 cells. This is the first study reporting a set of BRCA1-induced genes in breast carcinoma cells by the SSH technique. We suggest that some known genes identified in this study may provide new insights into the tumour-suppressor function of BRCA1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12470655     DOI: 10.1016/s0006-291x(02)02751-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The leucine-rich repeat signaling scaffolds Shoc2 and Erbin: cellular mechanism and role in disease.

Authors:  HyeIn Jang; Payton Stevens; Tianyan Gao; Emilia Galperin
Journal:  FEBS J       Date:  2020-07-06       Impact factor: 5.542

2.  Characterization of a 3;6 translocation associated with renal cell carcinoma.

Authors:  Rebecca E Foster; Mahera Abdulrahman; Mark R Morris; Elena Prigmore; Susan Gribble; Beeling Ng; Dean Gentle; Steven Ready; Phil M T Weston; Michael S Wiesener; Takeshi Kishida; Masahiro Yao; Val Davison; Jose Luis Barbero; Carol Chu; Nigel P Carter; Farida Latif; Eamonn R Maher
Journal:  Genes Chromosomes Cancer       Date:  2007-04       Impact factor: 5.006

3.  Correlation of invasion and metastasis of cancer cells, and expression of the RAD21 gene in oral squamous cell carcinoma.

Authors:  Gou Yamamoto; Tarou Irie; Tadateru Aida; Yuuki Nagoshi; Reiko Tsuchiya; Tetsuhiko Tachikawa
Journal:  Virchows Arch       Date:  2006-01-14       Impact factor: 4.064

4.  Epigenetic downregulation of human disabled homolog 2 switches TGF-beta from a tumor suppressor to a tumor promoter.

Authors:  Adèle Hannigan; Paul Smith; Gabriela Kalna; Cristiana Lo Nigro; Clare Orange; Darren I O'Brien; Reshma Shah; Nelofer Syed; Lindsay C Spender; Blanca Herrera; Johanna K Thurlow; Laura Lattanzio; Martino Monteverde; Meghan E Maurer; Francesca M Buffa; Jelena Mann; David C K Chu; Catharine M L West; Max Patridge; Karin A Oien; Jonathan A Cooper; Margaret C Frame; Adrian L Harris; Louise Hiller; Linda J Nicholson; Milena Gasco; Tim Crook; Gareth J Inman
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

5.  Elevated expression of MAC30 predicts lymph node metastasis and unfavorable prognosis in patients with epithelial ovarian cancer.

Authors:  Shanshan Yang; Huiyan Li; Yunduo Liu; Xiaoming Ning; Fanling Meng; Min Xiao; Deying Wang; Ge Lou; Yunyan Zhang
Journal:  Med Oncol       Date:  2012-12-18       Impact factor: 3.064

6.  Erbin and the NF2 tumor suppressor Merlin cooperatively regulate cell-type-specific activation of PAK2 by TGF-beta.

Authors:  Mark C Wilkes; Claire E Repellin; Min Hong; Margarita Bracamonte; Sumedha G Penheiter; Jean-Paul Borg; Edward B Leof
Journal:  Dev Cell       Date:  2009-03       Impact factor: 12.270

7.  Associations between single nucleotide polymorphisms in double-stranded DNA repair pathway genes and familial breast cancer.

Authors:  Mary E Sehl; Lucy R Langer; Jeanette C Papp; Lorna Kwan; Joyce L Seldon; Geovanni Arellano; Jean Reiss; Elaine F Reed; Sugandha Dandekar; Yael Korin; Janet S Sinsheimer; Zuo-Feng Zhang; Patricia A Ganz
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

8.  Erbin inhibits transforming growth factor beta signaling through a novel Smad-interacting domain.

Authors:  Fangyan Dai; Chenbei Chang; Xia Lin; Penggao Dai; Lin Mei; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2007-06-25       Impact factor: 4.272

9.  The Prognostic Effect of MAC30 Expression on Patients With Non-Small Cell Lung Cancer Receiving Adjuvant Chemotherapy.

Authors:  Hui Ding; Xianhua Gui; Xubo Lin; Ruhua Chen; Tieliang Ma; Yunlu Sheng; Hourong Cai; Yan Fen
Journal:  Technol Cancer Res Treat       Date:  2016-09-29

10.  Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis.

Authors:  Chun-Ming Chen; Richard R Behringer
Journal:  Genes Dev       Date:  2004-01-26       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.